3761 - 3770 of 5857 Results
Title
Year
-
OPENTitle: Regional neuropathology distribution and verbal fluency impairments in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.014Best OA location URL: http://manuscript.elsevier.com/S1353802019302354/pdf/S1353802019302354.pdfCitation Count: 19
- Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s disease2019OPENTitle: Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s diseaseJournal Name: Current Opinion in PhysiologyPublisher: Elsevier BVVol: 9Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cophys.2019.04.025Best OA location URL: https://doi.org/10.1016/j.cophys.2019.04.025Citation Count: 9
- Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort2019OPENTitle: Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohortJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 266Issue #: 8Start Page: 1927End Page: 1936Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-019-09348-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-019-09348-3.pdfCitation Count: 153
- The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss2019OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592621Citation Count: 9
-
OPENTitle: TREM2 brain transcript-specific studies in AD and TREM2 mutation carriersJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-019-0319-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-019-0319-3Citation Count: 81
- Diagnostic performance of the specific uptake size index for semi-quantitative analysis of I-123-FP-CIT SPECT: harmonized multi-center research setting versus typical clinical single-camera setting2019OPENTitle: Diagnostic performance of the specific uptake size index for semi-quantitative analysis of I-123-FP-CIT SPECT: harmonized multi-center research setting versus typical clinical single-camera settingJournal Name: EJNMMI ResearchPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13550-019-0506-9Best OA location URL: https://ejnmmires.springeropen.com/track/pdf/10.1186/s13550-019-0506-9Citation Count: 13
- Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression2019OPENTitle: Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progressionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0079-3Best OA location URL: https://www.nature.com/articles/s41531-019-0079-3.pdfCitation Count: 55
- Increased Cortical Thickness in Attentional Networks in Parkinson’s Disease with Minor Hallucinations2019OPENTitle: Increased Cortical Thickness in Attentional Networks in Parkinson’s Disease with Minor HallucinationsJournal Name: Parkinson's DiseasePublisher: WileyVol: 2019Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2019/5351749Best OA location URL: https://downloads.hindawi.com/journals/pd/2019/5351749.pdfCitation Count: 11
- Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse Model2019OPENTitle: Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse ModelJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00981Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00981/pdfCitation Count: 45
-
OPENTitle: Spring is in the air: seasonal profiles indicate vernal change of miRNA activityJournal Name: RNA BiologyPublisher: Informa UK LimitedVol: 16Issue #: 8Start Page: 1034End Page: 1043Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15476286.2019.1612217Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15476286.2019.1612217?needAccess=trueCitation Count: 14